Indies Pharma Jamaica Limited (JMSE:INDIES)
Jamaica flag Jamaica · Delayed Price · Currency is JMD
2.580
-0.120 (-4.44%)
At close: Aug 17, 2026

Indies Pharma Jamaica Balance Sheet

Millions JMD. Fiscal year is Nov - Oct.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Cash & Equivalents
450.74421.7221.97256.68234.63187.74
Cash & Short-Term Investments
450.74421.7221.97256.68234.63187.74
Cash Growth
40.57%89.98%-13.52%9.40%24.98%-40.14%
Accounts Receivable
139.33135.52168.1156.69106.83118.53
Other Receivables
152.496.4828.572.963.467.42
Receivables
291.82142196.67159.65110.29125.94
Inventory
155.74156.12248.58170.38175.51222.6
Prepaid Expenses
-135.1165.04110.6557.6136.31
Other Current Assets
0109.759.7426.3341.020.76
Total Current Assets
898.29964.62792723.7619.06573.35
Property, Plant & Equipment
1,5051,335915.81968.36949.4979.87
Long-Term Investments
17.2217.2216.3616.379.44146.75
Other Intangible Assets
525.24494.69461.71441.75379.31317.63
Long-Term Deferred Tax Assets
5.555.552.22.2--
Other Long-Term Assets
55.19238.26119.1287.8721.0118.94
Total Assets
3,0063,0552,3072,2402,0482,037

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Accounts Payable
22.04117.1441.6435.6416.3134.87
Accrued Expenses
6.46-----
Short-Term Debt
5.98.096.6411.997.863.44
Current Portion of Long-Term Debt
--805---
Current Portion of Leases
42.946.4243.3534.191.2246.58
Current Income Taxes Payable
42.692.4324.1815.74--
Other Current Liabilities
76.2459.6713.2745.2735.0813.32
Total Current Liabilities
196.27193.75934.08142.8460.4898.2
Long-Term Debt
1,0001,000-805805805
Long-Term Leases
158.85--50.921.25-
Other Long-Term Liabilities
16.73131.3979.4722.3924.5446.6
Total Liabilities
1,3721,3251,0141,021891.27949.8

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Common Stock
244.58244.58244.58244.58244.58244.58
Retained Earnings
496.48591.97590.58515.98453.9383.69
Comprehensive Income & Other
893.48893.48458.48458.48458.48458.48
Shareholders' Equity
1,6351,7301,2941,2191,1571,087
Total Liabilities & Equity
3,0063,0552,3072,2402,0482,037

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Apr '26 Oct '25 Oct '24 Oct '23 Oct '22 Oct '21
Total Debt
1,2081,015854.99902.1815.33855.02
Net Cash (Debt)
-756.95-592.81-633.02-645.42-580.7-667.27
Net Cash Growth
------
Net Cash Per Share
-0.57-0.44-0.48-0.48-0.44-0.50
Filing Date Shares Outstanding
1,3331,3331,3331,3331,3331,333
Total Common Shares Outstanding
1,3331,3331,3331,3331,3331,333
Working Capital
702.02770.87-142.08580.87558.59475.15
Book Value Per Share
1.231.300.970.910.870.82
Tangible Book Value
1,1091,235831.93777.3777.65769.12
Tangible Book Value Per Share
0.830.930.620.580.580.58
Land
-1,200765765.7792.7792.7
Machinery
-153.54118.05115.29118.53100.42
Leasehold Improvements
-111.95107.92103.79146.79138.54